Cargando…

Anakinra for severe forms of COVID-19

Detalles Bibliográficos
Autores principales:	Khan, Adil Rashid, Soneja, Manish, George, Netto, Wig, Naveet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413652/ https://www.ncbi.nlm.nih.gov/pubmed/32838319 http://dx.doi.org/10.1016/S2665-9913(20)30271-X

Ejemplares similares

Mavrilimumab for severe COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach
por: Tilangi, Praveen, et al.
Publicado: (2020)

False reassurance or inadequate drug levels?
por: Tirlangi, Praveen, et al.
Publicado: (2020)

COVID-19 and TB co-infection - 'Finishing touch'' in perfect recipe to 'severity’ or ‘death'
por: Kumar, Dr. Rohit, et al.
Publicado: (2020)

Clinical and Laboratory Features Associated with Acute Kidney Injury in Severe Malaria
por: Anghan, Hiren, et al.
Publicado: (2018)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Battling COVID-19: using old weapons for a new enemy
por: Kumar, Rohit, et al.
Publicado: (2020)

Pathophysiology of COVID-19-associated acute respiratory distress syndrome
por: Narayan, Ananthu, et al.
Publicado: (2021)

Anakinra for severe forms of COVID-19: a cohort study
por: Huet, Thomas, et al.
Publicado: (2020)

Prevalence of Long COVID-19 and its Impact on Quality of Life Among Outpatients With Mild COVID-19 Disease at Tertiary Care Center in North India
por: Sarda, Radhika, et al.
Publicado: (2022)

Is there antibody-dependent enhancement in SARS Coronavirus 2?
por: Kumar, Rohit, et al.
Publicado: (2020)

The Lazarus effect of very high-dose intravenous anakinra in severe non-familial CNS-HLH
por: Kavirayani, Akhila, et al.
Publicado: (2020)

436. SARS-CoV-2 Seropositivity and Association with Dengue Severity in Adults
por: Priyadarshi, Megha, et al.
Publicado: (2023)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

Risk Factors of Severity and Mortality Among COVID-19 Patients: A Prospective Observational Study From a Tertiary Care Center
por: Arunan, Bharathi, et al.
Publicado: (2022)

Positive Expiratory Pressure Oxygen Therapy for Respiratory Distress: A Single-arm Feasibility Trial
por: Dhochak, Nitin, et al.
Publicado: (2022)

Hydroxychloroquine pre-exposure prophylaxis for COVID-19 among healthcare workers: Initial experience from India
por: Kadnur, Harshith B., et al.
Publicado: (2022)

Mortality in systemic lupus erythematosus at a teaching hospital in India: A 5-year retrospective study
por: Bharath, Gangadharaiah, et al.
Publicado: (2019)

Lopinavir/ritonavir combination therapy amongst symptomatic coronavirus disease 2019 patients in India: Protocol for restricted public health emergency use
por: Bhatnagar, Tarun, et al.
Publicado: (2020)

2156. To Evaluate the Role of Kit-Based Loop-Mediated Isothermal Amplification (TB-LAMP) Assay in the Diagnosis of Tubercular Lymphadenitis
por: Nischal, Neeraj, et al.
Publicado: (2019)

Lyme arthritis: A prospective study from India
por: Gupta, Nitin, et al.
Publicado: (2019)

2654. Myocarditis in Dengue: A Prospective Observational Study
por: Soneja, Manish, et al.
Publicado: (2019)

375. Cryptococcal Antigenemia in Advanced HIV Infection
por: Ahuja, Jatin, et al.
Publicado: (2019)

Ambispective study of clinical picture, management practices and outcome of snake bite patients at tertiary care centre in Northern India
por: Jadon, Ranveer Singh, et al.
Publicado: (2021)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

ACE2 protein expression in lung tissues of severe COVID-19 infection
por: Gheware, Atish, et al.
Publicado: (2022)

Use of anakinra in severe COVID-19: A case report
por: Filocamo, Giovanni, et al.
Publicado: (2020)

Association of Dengue Virus and Leptospira Co-Infections with Malaria Severity
por: Mandage, Rajendra, et al.
Publicado: (2020)

Baroreflex sensitivity is impaired in survivors of mild COVID‐19 at 3–6 months of clinical recovery; association with carotid artery stiffness
por: Srivastava, Prachi, et al.
Publicado: (2023)

868. Early Organism Identification by Matrix Assisted Laser Desorption Ionization Time Of Flight Mass Spectrometry (MALDI TOF MS) Decreases the Time to Optimal Antibiotic Therapy for Common Bacterial Infections
por: Keri, Vishakh C, et al.
Publicado: (2023)

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
por: Dimopoulos, George, et al.
Publicado: (2020)

Gargle lavage as a viable alternative to swab for detection of SARS-CoV-2
por: Mittal, Ankit, et al.
Publicado: (2020)

Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience
por: Aggarwal, Anivita, et al.
Publicado: (2022)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ck5oej90l61ffbe2tbmf0oql6